Gastroenterology
Osteoactivin levels escalate in livers with acute injury
Published in Hepatitis Weekly, June 6th, 2005
According to recent research from Germany, "the transmembrane glycoprotein osteoactivin is expressed in osteoblasts, dendritic cells, and tumor cells. It is suggested to influence osteoblast maturation, cell adhesion, and migration. We studied osteoactivin expression within the liver."
"Expression of osteoactivin was analyzed by reverse transcription-polymerase chain reaction (RT-PCR), Northern blotting, in situ hybridization (ISH) and immunohistochemistry (IHC) comparing normal and acutely injured rat liver [induced by carbon tetrachloride (CCl4) administration], liver cell populations, and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2005-06-06)
More Articles from Hepatitis Weekly
- Cancer Prevention
Coffee consumption may lower one's risk for developing liver cancer - Immunization
Double dose hepatitis B vaccine protects HIV-infected adult patients - Transplant Medicine
Extrahepatic compartments contribute HCV circulation during liver transplants - Vaccine Development
Recombinant vaccine antigen protects monkeys against hepatitis E infection - Virology
Patients with occult hepatitis C may be able to infect others - Addiction Medicine
Antidepressant prophylaxis benefits HCV-positive drug users on interferon - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
